Variation in C-reactive Protein Following Weight Loss in Obese Insulin Resistant Postmenopausal Women: is there an Independent Contribution of Lean Body Mass?

Abstract

Background: We showed that obese insulin resistant postmenopausal women are characterized by higher lean body mass and elevated C-reactive protein. Although counterintuitive, we hypothesized that losses in muscle mass following caloric restriction and increase in muscle quality will be associated with improvements in glucose homeostasis through decreases in C-reactive protein.

Objectives: To determine 1) if improvements in C-reactive protein concentrations occurs through losses in lean body mass; and 2) if decreases in C-reactive protein levels contribute to improvements in insulin sensitivity.

Methods: 50 postmenopausal women (body mass index>26 kg/m^²) with impaired glucose disposal (<7.5 mg/kg/min) completed a 6-month caloric restriction program. Outcome measures were: Glucose disposal rate: M value (by hyperinsulinemic-euglycemic clamp), body composition (total, trunk, and appendicluar). LBM and FM by DXA), LBM index (LBM (kg)/height (m²), body fat distribution (VAT and SAT by CT scan) and plasma high-sensitive C-reactive protein (hsCRP) and interleukin-6 (Il-6).

Results: Significant correlations were observed between Δ hsCRP levels with Δ Il-6 (r=0.33, p≤0.05), Δ total LBM index (r=0.44, p≤0.01), Δ trunk LBM (r=0.38, p≤0.01) Δ SAT (r=0.35, p≤0.05) and ∆ glucose disposal rate (r=− 0.44, p≤0.01). After including all the correlated variables in Stepwise linear regression model, Δ LBM index was the only independent predictor of the reduction in hsCRP levels (R²=0.20, p≤0.01).

Conclusion: Losses in total lean body mass are independently associated with improvements in inflammatory state (CRP levels) in obese postmenopausal women with impaired glucose disposal.

Key words

inflammation - insulin resistance - caloric restrictions - body composition

• References

• 1 Ross R, Freeman J, Hudson R et al. Abdominal obesity, muscle composition, and insulin resistance in premenopausal women. J Clin Endocrinol Metab 2002; 87: 5044-5051
• 2 Peppa M, Koliaki C, Nikolopoulos P et al. Skeletal muscle insulin resistance in endocrine disease. J Biomed Biotechnol 2010; 2010 527850
• 3 Brochu M, Mathieu ME, Karelis AD et al. Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study. Obesity (Silver Spring) 2008; 16: 1085-1093
• 4 Karelis AD, Faraj M, Bastard JP et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005; 90: 4145-4150
• 5 You T, Ryan AS, Nicklas BJ. The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. J Clin Endocrinol Metab 2004; 89: 5517-5522
• 6 Krotkiewski M, Bjorntorp P. Muscle tissue in obesity with different distribution of adipose tissue. Effects of physical training. Int J Obes 1986; 10: 331-341
• 7 Karelis AD, Tousignant B, Nantel J et al. Association of insulin sensitivity and muscle strength in overweight and obese sedentary postmenopausal women. Appl Physiol Nutr Metab 2007; 32: 297-301
• 8 Aubertin-Leheudre M, Lord C, Goulet ED et al. Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women. Obesity (Silver Spring) 2006; 14: 2277-2283
• 9 Calder PC, Ahluwalia N, Brouns F et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr 2011; 106 (Suppl. 03) S5-S78
• 10 Barsalani R, Riesco E, Lavoie JM et al. Effect of exercise training and isoflavones on hepatic steatosis in overweight postmenopausal women. Climacteric 2012;
• 11 Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 2005; 69: 29-35
• 12 Sun L, Hu FB, Yu Z et al. Lean body mass, interleukin 18, and metabolic syndrome in apparently healthy Chinese. PLoS One 2011; 6: e18104
• 13 Puglisi MJ, Fernandez ML. Modulation of C-reactive protein, tumor necrosis factor-alpha, and adiponectin by diet, exercise, and weight loss. J Nutr 2008; 138: 2293-2296
• 14 Michigan A, Johnson TV, Master VA. Review of the Relationship between C-Reactive Protein and Exercise. Mol Diagn Ther 2011;
• 15 Campbell PT, Campbell KL, Wener MH et al. A yearlong exercise intervention decreases CRP among obese postmenopausal women. Med Sci Sports Exerc 2009; 41: 1533-1539
• 16 Barbat-Artigas S, Rolland Y, Vellas B et al. Muscle quantity is not synonymous with muscle quality. J Am Med Dir Assoc 2013; 14: 852e1-852e7
• 17 Tchernof A, Nolan A, Sites CK et al. Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 2002; 105: 564-569
• 18 Brochu M, Malita MF, Messier V et al. Resistance training does not contribute to improving the metabolic profile after a 6-month weight loss program in overweight and obese postmenopausal women. J Clin Endocrinol Metab 2009; 94: 3226-3233
• 19 Borai A, Livingstone C, Ferns GA. The biochemical assessment of insulin resistance. Ann Clin Biochem 2007; 44: 324-342
• 20 Weinsier RL, Nagy TR, Hunter GR et al. Do adaptive changes in metabolic rate favor weight regain in weight-reduced individuals? An examination of the set-point theory. Am J Clin Nutr 2000; 72: 1088-1094
• 21 Tremblay A, Pelletier C, Doucet E et al. Thermogenesis and weight loss in obese individuals: a primary association with organochlorine pollution. Int J Obes Relat Metab Disord 2004; 28: 936-939
• 22 Krauss RM, Deckelbaum RJ, Ernst N et al. Dietary guidelines for healthy American adults. A statement for health professionals from the Nutrition Committee, American Heart Association. Circulation 1996; 94: 1795-1800
• 23 DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223
• 24 Kyle UG, Schutz Y, Dupertuis YM et al. Body composition interpretation. Contributions of the fat-free mass index and the body fat mass index. Nutrition 2003; 19: 597-604
• 25 Kennedy RL, Chokkalingham K, Srinivasan R. Obesity in the elderly: who should we be treating, and why, and how?. Curr Opin Clin Nutr Metab Care 2004; 7: 3-9
• 26 Heilbronn LK, Noakes M, Clifton PM. Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vasc Biol 2001; 21: 968-970
• 27 Messier V, Karelis AD, Robillard ME et al. Metabolically healthy but obese individuals: relationship with hepatic enzymes. Metabolism 2010; 59: 20-24
• 28 Visser M, Pahor M, Taaffe DR et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 2002; 57: 326-M332
• 29 Cesari M, Kritchevsky SB, Baumgartner RN et al. Sarcopenia, obesity, and inflammation – results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr 2005; 82: 428-434
• 30 Kojima H, Aizawa Y, Yanai Y et al. An essential role for NF-kappa B in IL-18-induced IFN-gamma expression in KG-1 cells. J Immunol 1999; 162: 5063-5069
• 31 Amati F, Dube JJ, Alvarez-Carnero E et al. Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?. Diabetes 2011; 60: 2588-2597
• 32 Mazzali G, Di Francesco V, Zoico E et al. Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older women. Am J Clin Nutr 2006; 84: 1193-1199
• 33 Guo T, Jou W, Chanturiya T et al. Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One 2009; 4: e4937
• 34 Brandt C, Nielsen AR, Fischer CP et al. Plasma and muscle myostatin in relation to type 2 diabetes. PLoS One 2012; 7: e37236
• 35 Han HQ, Mitch WE. Targeting the myostatin signaling pathway to treat muscle wasting diseases. Curr Opin Support Palliat Care 2011; 5: 334-341
• 36 Goodpaster BH, Kelley DE, Wing RR et al. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 1999; 48: 839-847
• 37 Ryan AS, Nicklas BJ. Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes Care 2004; 27: 1699-1705
• 38 Wei Y, Chen K, Whaley-Connell AT et al. Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species. Am J Physiol Regul Integr Comp Physiol 2008; 294: R673-R680
• 39 Goran MI, Alderete TL. Targeting adipose tissue inflammation to treat the underlying basis of the metabolic complications of obesity. Nestle Nutr Inst Workshop Ser 2012; 73: 49-60
• 40 Ross R, Janiszewski PM. Is weight loss the optimal target for obesity-related cardiovascular disease risk reduction?. Can J Cardiol 2008; 24 Suppl D 25D-31D
• 41 Ross R, Dagnone D, Jones PJ et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 2000; 133: 92-103